These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33840641)

  • 1. [Mycoplasma genitalium: Prevalence of macrolide and fluoroquinolone resistance at the University Hospital of Tours, and check of the S-DiaMGRes
    Bras-Cachinho J; Lanotte P; Mereghetti L; Le Brun C
    Ann Biol Clin (Paris); 2021 Apr; 79(2):151-157. PubMed ID: 33840641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.
    Ke W; Li D; Tso LS; Wei R; Lan Y; Chen Z; Zhang X; Wang L; Liang C; Liao Y; Chen H; Liu Y; Zheng H; Yang L
    BMC Infect Dis; 2020 Dec; 20(1):950. PubMed ID: 33308173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Mycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland.
    Hokynar K; Hiltunen-Back E; Mannonen L; Puolakkainen M
    Int J STD AIDS; 2018 Aug; 29(9):904-907. PubMed ID: 29631509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.
    Kikuchi M; Ito S; Yasuda M; Tsuchiya T; Hatazaki K; Takanashi M; Ezaki T; Deguchi T
    J Antimicrob Chemother; 2014 Sep; 69(9):2376-82. PubMed ID: 24894419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of markers predictive of macrolide and fluoroquinolone resistance in
    Pitt R; Fifer H; Woodford N; Alexander S
    Sex Transm Infect; 2018 Feb; 94(1):9-13. PubMed ID: 28717051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of commercial PCR assays for antimicrobal resistance in Mycoplasma genitalium and estimation of resistance-mediated mutation prevalence in Moscow and Moscow region.
    Shedko ED; Khayrullina GA; Goloveshkina EN; Akimkin VG
    Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1413-1418. PubMed ID: 33515097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan.
    Deguchi T; Ito S; Yasuda M; Sato Y; Uchida C; Sawamura M; Manda K; Takanashi M; Kiyota H
    J Infect Chemother; 2018 Nov; 24(11):861-867. PubMed ID: 30190106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium.
    Tagg KA; Jeoffreys NJ; Couldwell DL; Donald JA; Gilbert GL
    J Clin Microbiol; 2013 Jul; 51(7):2245-9. PubMed ID: 23658265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Evaluation of Three Commercial PCR Assays for the Detection of Macrolide Resistance in Mycoplasma genitalium.
    Le Roy C; Bébéar C; Pereyre S
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31801835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.
    Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL
    Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Performance of Three Commercial Molecular Diagnostic Assays for the Detection of Fluoroquinolone Resistance-Associated Mutations in Mycoplasma genitalium.
    Gardette M; Hénin N; Le Roy C; Guiraud J; Touati A; Bébéar C; Pereyre S
    J Clin Microbiol; 2022 Dec; 60(12):e0113522. PubMed ID: 36321820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Macrolide and/or Fluoroquinolone Resistance Genes in
    Ljubin-Sternak S; Meštrović T; Marijan T; Anušić M; Šuto S; Vraneš J
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674404
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of markers predictive of macrolide and fluoroquinolone resistance in
    Day MJ; Cole MJ; Fifer H; Woodford N; Pitt R
    Sex Transm Infect; 2022 May; 98(3):215-218. PubMed ID: 34088790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of
    Wang L; Li Z; Wan C; Tian X; Liu H; Li Y
    Int J STD AIDS; 2023 Jul; 34(8):518-524. PubMed ID: 36929876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of macrolide and fluoroquinolone resistance-associated 23S rRNA and parC mutations in Mycoplasma genitalium by nested real-time PCR.
    He W; Yuan Y; Liang J; Fan X; Li L; Pan X
    Front Cell Infect Microbiol; 2023; 13():1271392. PubMed ID: 37928183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance: Prevalence and Risk Factors Among a 2013-2014 Cohort of Patients in Barcelona, Spain.
    Barberá MJ; Fernández-Huerta M; Jensen JS; Caballero E; Andreu A
    Sex Transm Dis; 2017 Aug; 44(8):457-462. PubMed ID: 28703723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia.
    Shipitsyna E; Rumyantseva T; Golparian D; Khayrullina G; Lagos AC; Edelstein I; Joers K; Jensen JS; Savicheva A; Rudneva N; Sukhanova L; Kozlov R; Guschin A; Unemo M
    PLoS One; 2017; 12(4):e0175763. PubMed ID: 28407014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
    Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS
    Lancet Infect Dis; 2020 Nov; 20(11):1302-1314. PubMed ID: 32622378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options.
    Pond MJ; Nori AV; Witney AA; Lopeman RC; Butcher PD; Sadiq ST
    Clin Infect Dis; 2014 Mar; 58(5):631-7. PubMed ID: 24280088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014.
    Muller EE; Mahlangu MP; Lewis DA; Kularatne RS
    BMC Infect Dis; 2019 Feb; 19(1):148. PubMed ID: 30760230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.